- Rejects the ad
- Semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro or Zepbound as keywords
- Prescription-drug ads from a clinic that prescribes online as telemedicine
- Unrealistic weight-loss claims or numbers on a scale
- Risks the account
- Trademark bidding on drug brands
- Misspellings and workarounds that Google treats as circumvention
- Requires
- Nothing, for program and clinic intent: medical weight loss clinic, weight loss doctor near me, GLP-1 program, physician supervised weight loss
- Since October 29, 2025, an in-person clinic can name semaglutide or tirzepatide in US ad text and on its landing page
- How we run it
- Phase one runs the open keywords immediately, with ad copy about the program, the supervision and the clinic, and the medication named where it helps. It lands on a program page with medication detail below the fold and no price list.
Semaglutide clinic ads
Google Ads for weight loss clinics: what runs in 2026
Short answer
As of October 2026, a medical weight loss clinic can run Google Ads on program and clinic intent without any certification, and since October 29, 2025 an in-person clinic can also name semaglutide or tirzepatide in US ad text and on its landing page without it. Keyword-targeting those drug terms still needs Google's certification, and a clinic that prescribes online as telemedicine needs certification before prescription-drug ads serve. MedScale Health runs weight loss clinic ads in two phases on that basis: program-intent search with the medication named in the copy, then drug-term keywords once certification lands, with landing pages written so the reviewer sees a clinic and the patient sees a program.
Checked against the platform policy pages on October 5, 2026. By Michael Borgia, MedScale Health.
What this means for you
- Medical weight loss clinic, GLP-1 program near me and physician supervised weight loss are open keywords today. Semaglutide and tirzepatide keywords are certification-gated; naming them in an in-person clinic's ad text is not.
- The landing page is judged as part of the ad. A page that lists compounded semaglutide with a price reads as a pharmacy and gets the program-intent ads disapproved too.
- Trademark bidding on drug brand names and misspellings used to dodge certification are account-level risks, not ad-level ones.
- Certification is worth it when the clinic wants the drug-term keyword auction, and required when it prescribes online. For telemedicine it is LegitScript first, then Google.
- Cost per booked consult is the number. Clicks on drug terms from people comparing prices rarely book a supervised program.
Policy reality
What each platform allows for medical weight loss clinics.
Positions are read from each platform's own policy pages, with the source linked on every row and the date we last checked it. Where a row names a certification it is LegitScript unless the row says Google. LegitScript is the third-party certification Meta and Google require before a pharmacy or telehealth provider can promote prescription drugs.
Checked 2026-10-05How the platforms compare
- Rejects the ad
- Claims that compounded products are FDA-approved or equivalent to branded drugs
- Outcome claims
- Risks the account
- Losing LegitScript certification, which cancels Google's certification with it
- Pages that drift from clinic to pharmacy after approval
- Requires
- Google's Healthcare and medicines certification, filed at the account level with the clinic's domain, to keyword-target drug terms
- A clinic or telehealth arm that prescribes online needs LegitScript Healthcare Merchant Certification first, then Google's certification, before prescription-drug ads serve
- How we run it
- Phase two adds drug-term keyword campaigns, with landing pages that state the compounding status and the prescriber oversight the way LegitScript expects. Certification takes weeks, so phase one keeps campaigns running while it moves.
- Rejects the ad
- Close-ups pinching fat and statements of inferiority about the body
- Second-person hooks about the reader's body
- Drug names without certification
- Risks the account
- Pharmacy-style landing pages
- Pixel events named after the drug
- Requires
- LegitScript certification and Meta authorization to name a prescription weight-loss drug; clinic ads that do not name one run without it
- Since July 22, 2026, 18+ weight-loss ads may show before-and-after; showing the program in use was already allowed
- How we run it
- Same two-phase logic: program and provider creative first, drug-named creative after certification, one site built to hold up under both reviews. Our house rule keeps before-and-after out of the ads we run.
The two auctions a weight loss clinic is choosing between
There are two distinct searches happening in this category. One is the person looking for a clinic: medical weight loss near me, weight loss doctor, GLP-1 program with supervision. The other is the person looking for a drug: semaglutide cost, tirzepatide online, a brand name plus coupon. Google lets any clinic bid on the first without certification and reserves keyword-targeting of the second for certified advertisers. Since October 29, 2025, an in-person clinic can still name the drug in its ad text and on its landing page, so the clinic auction can carry the medication name without entering the drug auction. The clinic auction is smaller but the intent is closer to what a supervised program sells, and the drug auction is larger but full of price-shoppers and national telehealth brands. Most clinics we see are trying to compete in the drug auction without the certification to enter it, getting disapproved, and never building the program-intent campaigns that would have booked consults from the first week.
Phase one: the campaigns that run today
Phase one is built entirely on open terms. Campaigns are split by intent: clinic intent (medical weight loss clinic, weight loss doctor, obesity medicine clinic plus city), program intent (GLP-1 program, physician supervised weight loss, medically supervised weight loss plan) and comparison intent (medical weight loss vs telehealth, in-person weight loss program). Ad copy describes the program and the supervision: labs, a provider visit, monthly follow-up, medication options discussed at the consult. It can name the medication the clinic offers, since US ad text no longer needs certification for that, and it never promises a number. Negative keyword lists exclude brand names, compounded, online pharmacy and price terms so the budget stays with people who want a clinic. Call extensions with tracking, location extensions and a booking-first landing page complete the setup. Bid strategy starts on maximise conversions with a target cost per consult once thirty or so conversions have been recorded, and location targeting is drawn tightly around the practice, because a supervised program needs patients who can come in for labs.
A negative keyword starter list
A weight loss clinic account starts with negatives in place, grouped by theme into shared lists that apply to every campaign. Drug shopping: brand names, compounded, online pharmacy, buy, order, without a prescription, coupon. These pull people who want a product shipped, not a supervised program, and the drug names are certification-gated as keywords anyway. Bargain hunting: cheapest, free, discount code. Research and information: side effects, lawsuit, studies, clinical trial, what is. Do it yourself: diet plan, supplements, natural, over the counter, recipes. Jobs and training: jobs, careers, salary, course, training. Out of area: cities beyond the service radius, and online or telehealth terms if the clinic only sees patients in person. Coverage: insurance terms if the program is self-pay. We start from themes rather than a fixed list because the right negatives depend on what the clinic sells, then read the search terms report every week, add new negatives and give phrases that book consults their own ad group. Once certification lands, the drug-name negatives come off the campaigns built to bid on those terms.
Landing pages the reviewer reads as a clinic
Google reviews the landing page as part of the ad, and it is the page that gets most program-intent ads disapproved. A page that lists compounded semaglutide and tirzepatide with monthly prices and an order button is an online pharmacy in the reviewer's eyes, and the certification rules for online pharmacies then apply to every ad pointing at it. The page that passes opens with the clinic, the provider and what the program involves, offers a consult booking above the fold, and explains medication options in a lower section in measured language: compounded products described as compounded, not FDA-approved, prescribed by the clinic's provider when appropriate, never presented as equivalent to the branded drug. That same page satisfies LegitScript when the clinic later applies for certification, so nothing has to be rebuilt for phase two.
Measuring to the booked consult
The campaigns bid toward one conversion, the booked consult. Calls, form starts and page views are reported but never bid on, because a clinic is paid by patients who come in, not by clicks on a phone number. Bookings made on a scheduling or intake platform are tracked server-side: a bridge token carries the click ID from the ad into the booking, and the confirmed consult is sent back to Google under a neutral event name. No names, emails, phone numbers, IP addresses or browser IDs reach Google, and neither does any weight, BMI or medication detail. Calls are tracked with numbers that swap per campaign, so a phone booking is credited to the keyword that produced it. Where the clinic can share it, the program start is sent back the same way, and the Monday report shows cost per consult and cost per start by keyword. Budget then moves toward the terms that bring patients who begin the program, and away from terms that only bring price comparisons.
Phase two: certification and the drug-term auction
Certification opens the drug-term keyword auction, which is larger. For a clinic that prescribes and ships medication online, it is also required before prescription-drug ads serve, and the sequence is LegitScript first, through its Healthcare Merchant Certification program for the prescribing entity and its domain, then Google's Healthcare and medicines certification, filed at the account level with the certified domain. For an in-person clinic that only wants drug-term keywords, Google's certification is the gate, and the audit confirms which path applies before anything is filed. LegitScript's published fees are $975 to apply and $2,150 a year per website, and its review examines licensing, prescribing practice, privacy and marketing claims, which is why the landing pages are built to its standard from day one. Once Google's certification is active, drug-term campaigns launch with the same measured landing pages, and the account is watched for anything that could put the certification at risk, because losing LegitScript cancels the Google permission with it.
What we measure, and how MedScale Health runs it
The number is cost per booked consult, with consults attributed to the keyword and campaign through server-side tracking and a bridge token that carries the click ID into the clinic's scheduling or intake platform. We also report cost per program start where the clinic can share it, because the gap between consults and starts tells you which keywords bring candidates and which bring shoppers. Week one is the policy read of the account and the pages, including the negative keyword lists and any brand-name bidding that has to stop. Week two puts tracking live with generic event names. Phase one launches by Day 14. Certification, where the clinic wants it, runs in parallel with the paperwork handled and the pages already compliant, so phase two is a launch rather than a rebuild.
Results from the accounts
Anonymised results from telehealth brands and clinics that run on our tracking. Names are withheld. Results vary by brand, offer and budget.
- Four times the rate from visitor to member
- For a GLP-1 membership brand, visitors who came in through one entry page became paying members at 1.8%, against 0.4% for visitors who arrived on the homepage.
From the answers library
Guides for weight loss clinics.
Can You Advertise GLP-1 on Google Ads?
As of October 2026, a GLP-1 telehealth brand can advertise on Google Ads once it holds LegitScript accreditation and Google's certification, which Google requires before prescription drug service ads serve in the United States. MedScale Health, a paid ads agency for US telehealth brands and clinics, sequences certification, then landing pages, then keywords. An in-person clinic may name semaglutide or tirzepatide in US ad text and landing pages without certification since October 29, 2025, but needs certification to keyword-target those terms.
Reviewed October 24, 2026
What Are the Rules for Medical Weight Loss Clinic Ads on Meta and Google?
As of October 2026, an in-person medical weight loss clinic can advertise its program on Meta and Google without certification, and may name semaglutide in US Google ad text and on its page, but not keyword-target it. MedScale Health, a paid ads agency for US telehealth brands and clinics, pre-clears clinic creative against Meta's health and personal attributes standards before spend. On Meta, only telehealth providers, pharmacies and manufacturers can be authorized to promote the drug; ads target adults, and inferiority statements, pinched-fat close-ups and "tired of the weight?" hooks fail.
Reviewed October 24, 2026
Can You Name Ozempic, Wegovy or Zepbound in Your Ads?
As of November 2026, a telehealth brand can name Ozempic, Wegovy or Zepbound in ads only once certified: Google requires telemedicine providers to be certified regardless, Meta treats a named prescription drug as promotion needing LegitScript and its authorization, and trademark risk applies on top. MedScale Health, a paid ads agency for US telehealth brands and clinics, generally keeps branded drug names out of paid creative, because the traffic rarely justifies the exposure. An in-person clinic may name the drugs in US Google ads without certification but not keyword-target them.
Reviewed November 9, 2026
What Are the Rules for Advertising Compounded Semaglutide in 2026?
As of November 2026, compounded semaglutide can be advertised only on much narrower ground than during the shortage. MedScale Health, a paid ads agency for US telehealth brands and clinics, rewrites claims built on the shortage-era footing and labels compounded semaglutide as compounded, not FDA-approved. FDA resolved the semaglutide shortage on February 21, 2025, enforcement discretion ended in April and May 2025, and FDA's June 15, 2026 guidance tells telehealth companies not to present compounded drugs as generic, equivalent or FDA-approved.
Reviewed November 9, 2026
GLP-1 Ad Examples That Pass Meta Review
As of October 2026, GLP-1 ads that pass Meta review share one structural property: nothing in them asserts anything about the person seeing them. MedScale Health, a paid ads agency for US telehealth brands and clinics, builds GLP-1 creative around the program, the clinician and the mechanism rather than the patient, and the eight concept ads on this page show it for a fictional brand. Program-first creative stays clear of Meta's personal attributes rule and of the claims Meta still bans: inferiority statements, pinched-fat close-ups and timed promises without a qualifier.
Reviewed October 24, 2026
LegitScript and Google Ads: Which Do You Need, and How Do You Apply?
As of November 2026, a US telehealth provider or online pharmacy needs two certifications to advertise prescription drug services on Google, in order: LegitScript (or NABP, for a pharmacy) first, then Google's own healthcare certification. MedScale Health, a paid ads agency for US telehealth brands and clinics, files both in that order and has Google's form ready the day the LegitScript certificate lands. Google's form, Apply for healthcare-related advertising, is filed from the child Google Ads account with its customer ID and the certified domain.
Reviewed November 9, 2026
Google Ads for Weight Loss Clinics questions
What buyers ask before they book.
Can our clinic bid on semaglutide keywords?
Only with Google's certification. Since October 29, 2025, an in-person US clinic can name semaglutide or tirzepatide in ad text and on its landing page without certification, but keyword-targeting the terms still needs it, and bidding on them uncertified is disapproved or worse. Program and clinic keywords such as medical weight loss clinic and GLP-1 program are open today and sit closer to what a supervised program sells.
Why were our clinic ads disapproved when they never mentioned a drug?
Almost always the landing page. Google reviews the page as part of the ad, and a page that lists medications with prices or reads like an online pharmacy triggers the prescription-drug rules for every ad pointing at it. Restructure the page around the program and the provider, move medication detail below the fold in measured language, remove the price list, and the same ads usually clear on resubmission.
Is LegitScript certification worth it for a single-location clinic?
If the clinic prescribes and ships medication online, certification isn't optional: it is required before prescription-drug ads serve. If the clinic sells an in-person supervised program, phase one on program intent, with the drug named in the ad text, often covers it, and Google's certification is only needed for drug-term keywords. The Growth Audit sizes both auctions for your metro before you spend on an application.
How long does Google certification take for a weight loss clinic?
LegitScript reviews in weeks rather than days and depends on how complete the documentation is and how quickly questions are answered; expedited review is available for an additional fee. Google's certification is a separate application filed after LegitScript approval. MedScale runs phase one throughout so the clinic is booking consults while the paperwork moves.
How do you know which keywords produce program starts rather than shoppers?
Because the consult and the program start are tracked server-side with the click ID attached, and the clinic's intake platform reports the start back through a bridge token. Cost per consult and cost per start are reported by keyword weekly, and budget moves toward the terms that produce patients who begin a supervised program rather than people comparing medication prices.
How much should a weight loss clinic spend on Google Ads to start?
Enough to fund one or two campaigns in a tight radius, rather than a thin budget spread across every keyword. Cost per click varies by metro and by month, so the right figure comes from your own market, and the free Growth Audit checks it before you commit. Ad spend is paid to Google from the clinic's own account. MedScale's management fee is separate, set by scope after the audit, and runs month to month. Judge the budget on cost per booked consult, not on clicks.
Do the rules differ for a local clinic and a telehealth weight loss program?
Yes. An in-person clinic can run program and clinic keywords without certification and, in the US, name semaglutide or tirzepatide in its ad text and on its landing page. A program that prescribes online is a telemedicine provider: it needs LegitScript Healthcare Merchant Certification, then Google's certification, before prescription-drug ads serve. Targeting differs too. A clinic draws a tight radius around the practice for labs and visits; a telehealth program targets the states where its providers are licensed.
How long until our Google Ads start serving?
For program and clinic campaigns, live by Day 14 from the start: access, audit and tracking in week one, then the landing page and ads in week two. Google reviews most ads within one business day once they are submitted. Drug-term keywords wait for certification, and for a clinic that prescribes online the LegitScript and Google applications come first, which takes weeks rather than days. Phase one keeps the clinic booking consults while that runs.
From the answers library
The answers behind this page.
Can You Advertise GLP-1 on Google Ads?
As of October 2026, a GLP-1 telehealth brand can advertise on Google Ads once it holds LegitScript accreditation and Google's certification, which Google requires before prescription drug service ads serve in the United States. MedScale Health, a paid ads agency for US telehealth brands and clinics, sequences certification, then landing pages, then keywords. An in-person clinic may name semaglutide or tirzepatide in US ad text and landing pages without certification since October 29, 2025, but needs certification to keyword-target those terms.
Reviewed October 24, 2026
What Are the Rules for Medical Weight Loss Clinic Ads on Meta and Google?
As of October 2026, an in-person medical weight loss clinic can advertise its program on Meta and Google without certification, and may name semaglutide in US Google ad text and on its page, but not keyword-target it. MedScale Health, a paid ads agency for US telehealth brands and clinics, pre-clears clinic creative against Meta's health and personal attributes standards before spend. On Meta, only telehealth providers, pharmacies and manufacturers can be authorized to promote the drug; ads target adults, and inferiority statements, pinched-fat close-ups and "tired of the weight?" hooks fail.
Reviewed October 24, 2026
Can You Name Ozempic, Wegovy or Zepbound in Your Ads?
As of November 2026, a telehealth brand can name Ozempic, Wegovy or Zepbound in ads only once certified: Google requires telemedicine providers to be certified regardless, Meta treats a named prescription drug as promotion needing LegitScript and its authorization, and trademark risk applies on top. MedScale Health, a paid ads agency for US telehealth brands and clinics, generally keeps branded drug names out of paid creative, because the traffic rarely justifies the exposure. An in-person clinic may name the drugs in US Google ads without certification but not keyword-target them.
Reviewed November 9, 2026
What Are the Rules for Advertising Compounded Semaglutide in 2026?
As of November 2026, compounded semaglutide can be advertised only on much narrower ground than during the shortage. MedScale Health, a paid ads agency for US telehealth brands and clinics, rewrites claims built on the shortage-era footing and labels compounded semaglutide as compounded, not FDA-approved. FDA resolved the semaglutide shortage on February 21, 2025, enforcement discretion ended in April and May 2025, and FDA's June 15, 2026 guidance tells telehealth companies not to present compounded drugs as generic, equivalent or FDA-approved.
Reviewed November 9, 2026
Next step
Start with the audit.
We read your live ads, landing pages and tracking against the rules on this page and send back the flags and a written ninety-day plan in five business days.
Growth audit
See where your growth is leaking.
We audit the ads, the landing pages, the tracking and the compliance posture, then hand you the roadmap. The people writing it have run the same funnel from the inside. You keep it whether or not we work together.
- Reviewed
- Funnel, tracking, and compliance posture
- Discussed
- One 30-minute call with the operator on your account
- Delivered
- A written roadmap within 5 business days